Reportlinker finds all market research
reports published by official sources!
Investor presentation: Pathology in The United States for Year 2011
- This 22-page company report was published in March 2011.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Pathology Industry in the United States : Latest Downloads
Company Report: Pathology in The United States for Year 2013
- Company report
- May 2013
- 9 pages
... Stribild gilead hiv-1 infection aug. 27 Neutroval sicor biotech neutropenia aug. 29 Linzess forest ibs aug. 30 Xtandi astellas prostate cancer aug. 31 Bosulif pfizer leukemia sep. 4 Aubagio sanofi multiple ...
Company Report: Pathology in The United States for Year 2013
- Company report
- May 2013
- 9 pages
Company Report: Pathology in The United States for Year 2013
- Company report
- May 2013
- 6 pages
Morphosys Ag - Company Report For Year 2013
21 days agoCompany Report: Pathology In The United State ...
2 months agoMerck Research Laboratories - Company Report ...
2 months agoCompany Report: Pathology In The United State ...
2 months agoLevel 3 Communications Inc. - Company Report ...
2 months agoCompany Report: Hair Loss In The United State ...
3 months agoMarket Figures
Pharmaceutical Key Market Figures In The United States
7 months ago
U.s. Pharmaceutical Sector : Key Market Figures
7 months ago
Technology Trends
Pharmaceutical Industry Trends In The United States An...
10 months ago
Mental Disorder Sector Trends In The United States
12 months ago
More Reports:
Pathology in Australia (47)
Pathology in Canada (45)
Pathology in China (14)
Pathology in India (36)
Pathology in Ireland (20)
Company Reports
Pathology Industry in the United States : Latest Reports
Drug and Medication Industry: Prostate Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Drug and Medication Industry: Ovarian Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- April 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013', provides an overview ...
More Reports:
Pathology in China (77)
Pathology in France (143)
Pathology in Germany (145)
Pathology in Italy (144)
Pathology in Japan (152)
Pathology in Spain (144)
Company Profiles
10 CompaniesAstraZeneca PLC
United KingdomWolters Kluwer N.V.
NetherlandsUniversity of Pittsburgh Medical Center
United StatesBeth Israel Deaconess Medical Center Inc.
United StatesCare Investment Trust Inc.
United StatesProvectus Pharmaceuticals Inc.
United StatesAltarum Institute
United StatesGeneral Electric Co.
United StatesGeneral Hospital Corp.
United StatesTransnuclear Inc.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
